# Bank of Nova Scotia: overview

BNS · NYSE · CIK 9631 · [Financials](/sectors/financials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/bns.md) · [Financials](/companies/bns/financials.md) · [Filings](/companies/bns/filings.md) · [Insiders](/companies/bns/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

Not reported.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [31.3](/filings/0001193125-22-294230.md) | [31.4](/filings/0001193125-23-284197.md) | [32.2](/filings/0001193125-24-269887.md) | [33.7](/filings/0001193125-25-304643.md) | [37.7](/filings/0001193125-25-304643.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [30.8%](/filings/0001193125-22-294230.md) | [31.6%](/filings/0001193125-23-284197.md) | [22.8%](/filings/0001193125-24-269887.md) | [23.0%](/filings/0001193125-25-304643.md) | [20.6%](/filings/0001193125-25-304643.md) |
| Diluted EPS | $ per share | [7.70](/filings/0001193125-22-294230.md) | [8.02](/filings/0001193125-23-284197.md) | [5.72](/filings/0001193125-24-269887.md) | [5.87](/filings/0001193125-25-304643.md) | [5.67](/filings/0001193125-25-304643.md) |
| Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: ifrs-full:Revenue.
- Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue.
- Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:Revenue.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:Revenue.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bns/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $5.72bn | 65,848,379 |  | Reduced −5,999,289 |
| [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $4.51bn | 51,924,070 |  | Reduced −4,145,336 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.10bn | 35,706,610 |  | Added +23,327 |
| [CIBC WORLD MARKET INC.](/funds/1421224.md) | 2026-06-30 | $2.19bn | 25,213,679 |  | Reduced −764,102 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $1.60bn | 18,387,259 |  | New +18,387,259 |
| [1832 Asset Management L.P.](/funds/944388.md) | 2026-06-30 | $1.41bn | 16,250,132 |  | Reduced −2,004,144 |
| [NATIONAL BANK OF CANADA /FI/](/funds/926171.md) | 2026-06-30 | $1.36bn | 15,686,925 |  | Reduced −723,071 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.28bn | 14,311,695 |  | Added +1,471,882 |
| [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $1.25bn | 14,446,900 | Put | Added +52,200 |
| [TD Asset Management Inc](/funds/1056053.md) | 2026-06-30 | $1.22bn | 14,090,469 |  | Reduced −5,091,494 |

## Recent filings

[All more than 10,000 filings](/companies/bns/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 10:44 ET | [6-K](/filings/0001279569-26-000993.md) | Report of a foreign private issuer, period 2026-10-21 | 0001279569-26-000993 |
| 2026-10-16 | 10:37 ET | [6-K](/filings/0001193125-26-423543.md) | Report of a foreign private issuer, period 2026-10-16 | 0001193125-26-423543 |
| 2026-10-02 | 06:44 ET | [6-K](/filings/0001279569-26-000945.md) | Report of a foreign private issuer, period 2026-10-02 | 0001279569-26-000945 |
| 2026-10-01 | 10:03 ET | [6-K](/filings/0001193125-26-410050.md) | Report of a foreign private issuer, period 2026-10-01 | 0001193125-26-410050 |
| 2026-10-01 | 09:40 ET | [6-K](/filings/0001839882-26-048517.md) | Report of a foreign private issuer, period 2026-10-01 | 0001839882-26-048517 |
| 2026-08-25 | 07:25 ET | [6-K](/filings/0001193125-26-364142.md) | Report of a foreign private issuer, period 2026-08-25 | 0001193125-26-364142 |
| 2026-08-25 | 07:21 ET | [6-K](/filings/0001193125-26-364131.md) | Report of a foreign private issuer, period 2026-08-25 | 0001193125-26-364131 |
| 2026-08-25 | 07:16 ET | [6-K](/filings/0001193125-26-364120.md) | Report of a foreign private issuer, period 2026-08-25 | 0001193125-26-364120 |
| 2026-08-25 | 07:11 ET | [6-K](/filings/0001193125-26-364115.md) | Report of a foreign private issuer, period 2026-07-31 | 0001193125-26-364115 |
| 2026-08-25 | 07:01 ET | [6-K](/filings/0001193125-26-364103.md) | Report of a foreign private issuer, period 2026-08-25 | 0001193125-26-364103 |

## Latest annual report

[Form 40-F for the fiscal year ended Oct 31, 2025](/filings/0001193125-25-304643.md), filed Dec 2, 2025.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 9631
- Tickers: BNS
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: Z4
- Filer category: not reported

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 14:01 ET. No prices; not investment advice.